Current clinical evidence shows no direct pharmacokinetic interactions between GLP-1 receptor agonists like semaglutide and standard thyroid replacement therapies, but individual monitoring remains essential for safe, effective treatment
[2] [3] NICE guidance for obesity management acknowledges this uncertainty whilst supporting the use of these agents when clinically appropriate, emphasising the importance of patient selection and monitoring
Schedule Your Consultation Take the first step toward a healthier life by scheduling a consultation at our Dr
Naomi Loomis: Olympias investing in research and development on compounding other GLP-1s that may go on shortage or potential combination GLP-1s to have more accessible options, which will help keep patients on track with their weight loss and diabetes management
Choose complex carbohydrates, such as whole grain breads and cereals, brown rice, oatmeal, quinoa, legumes and starchy vegetables like sweet potatoes and squash
We earn commissions from these links.